The Top 50 Healthcare Technology CEOs of 2023

The Healthcare Technology Report is pleased to announce The Top 50 Healthcare Technology CEOs of 2023. This year’s list includes those select individuals who have demonstrated remarkable leadership over the past year. They have brought some of the most advanced healthcare solutions to market from innovative software platforms to medical devices to therapeutics, and beyond while improving the patient care experience and outcomes. These accomplished individuals embody what it means to be a great leader in the modern era leveraging keen business acumen with a consistent drive to make the world a healthier place.

As CEO of Accolade, Rajeev Singh has guided his company through a highly anticipated IPO and managed to integrate four companies into the fold—bringing in more than $1 billion in acquisitions. Meanwhile, Alyson Watson of Modern Health, who brought in more than $170 million in less than two years, leads the fastest entirely female-founded company in the U.S. to reach unicorn status. And at Integra LifeSciences, Jan De Witte’s guidance led to exponential revenue growth in 2022 compared to the previous year, driven by several key product introductions and strategic actions to optimize the company’s business and product portfolios.

This year’s awardees have never shied away from putting forth resources to aid in the industry-wide mission of improving global health and have additionally made waves in their local communities by serving on academic committees and charity organization boards. Please join us in celebrating the achievements of The Top 50 Healthcare Technology CEOs of 2023.


1. Michael Mahoney
Company: Boston Scientific
Title: Chief Executive Officer

Michael Mahoney is the Chief Executive Officer of Boston Scientific Corporation and Chairman of the company’s Board of Directors. Boston Scientific is a global medical technology leader with approximately $12.7 billion in annual revenue and commercial representation in more than 130 countries. Under Mahoney’s leadership, Boston Scientific is delivering on its mission to transform lives through innovative medical solutions that improve the health of patients around the world.

Since joining Boston Scientific, Mahoney has focused the company on addressing the needs of the evolving healthcare landscape by driving improvements to patient outcomes and increasing healthcare economic efficiency and access. Boston Scientific has brought many transformational medical devices to market while creating significant value to its shareholders with him at the helm.

Mahoney’s career spans more than 25 years of success building market-leading medical device, capital equipment, and healthcare IT businesses. Prior to Boston Scientific, he served as Worldwide Chairman of the Medical Devices and Diagnostics (MD&D) division of Johnson & Johnson. Preceding that, he was President and CEO of Global Healthcare Exchange (GHX). For the first 12 years of his career, Mahoney advanced through a series of leadership roles at General Electric Medical Systems, including General Manager of the company’s Healthcare Information Technology business. He earned his Bachelor of Business Administration in finance from the University of Iowa and his Master of Business Administration from Wake Forest University.


2. Michelle Keefe
Company: Syneos Health®
Title: Chief Executive Officer

Michelle Keefe is the Chief Executive Officer of Syneos Health, a leading fully integrated biopharmaceutical solutions organization built to accelerate customer success. The company translates unique clinical, medical affairs, and commercial insights into outcomes to address modern market realities—sharing insights, using the latest technologies, and applying advanced business practices to speed customers’ delivery of important therapies to patients.

Keefe has steered Syneos Health to make significant strides in becoming a tech-enabled company, delivering technology and data solutions that accelerate clinical development and elevate commercial performance for biopharma customers. In Q1 2023, Syneos Health announced a strategic partnership with Microsoft to develop an advanced analytics platform that enables agile deployment of machine learning (ML) to support the analysis, design, and execution of clinical trials and commercial programs worldwide. During this time, the company also announced a collaboration with KX to utilize AI and ML to improve clinical trial efficiency, speeding time to market for life-changing therapies for patients.

Keefe serves on the board of directors of Syneos Health (NYSE: SYNH) and is a member of the Healthcare Businesswomen’s Association Global Advisory Board. A champion for inclusive, collaborative cultures, Keefe is an Executive Sponsor of the Syneos Health Women’s Group, Diversity, Equity & Inclusion Council, and Syneos Heath Rising Star and Luminary employee recognition program. Keefe holds a Bachelor of Science in marketing from Seton Hall University.


3. Helen Giza
Company: Fresenius Medical Care
Title: Chief Executive Officer

Helen Giza is the Chief Executive Officer of Fresenius Medical Care, the world’s leading provider of products and services for people with chronic kidney failure. Prior to her appointment as CEO, she served as the Chief Financial Officer of the company. She will continue to fulfill her responsibilities as CFO until a successor is named for that position.

Helen Giza joined Fresenius Medical Care in 2019 as the CFO. In 2021, she took on the additional role of Chief Transformation Officer, where she led the FME25 transformation program. Before joining Fresenius Medical Care, she held the position of Chief Integration and Divestiture Management Officer at Takeda Pharmaceuticals starting in 2018. Prior to that, she served as the CFO of Takeda's U.S. business unit from 2008 onwards.

Before her time at Takeda, Helen Giza held various international finance and controlling positions. She worked at companies such as TAP Pharmaceuticals and Abbott Laboratories. She is a Chartered Certified Accountant in the United Kingdom and holds a Master of Business Administration degree from the Kellogg School of Management at Northwestern University in Evanston, Illinois, USA.


4. Jan De Witte
Company: Integra LifeSciences
Title: President and Chief Executive Officer

Since joining Integra in 2021, Jan De Witte has made a significant impact in strengthening the company’s position as a world leader in restoring patients' lives with breakthrough technologies in neurosurgical and regenerative care. His guidance helped 2022 revenues grow exponentially compared to the previous year, driven by several key product introductions and strategic actions to optimize the company’s business and product portfolios.

In addition, De Witte worked with the leadership team to rejuvenate and refocus the company’s integrated business strategy and rally the organization around five key strategic pillars that will drive growth and profitability in the coming years. Under these key pillars, he has made savvy choices to focus on growth drivers, including strengthening clinical capabilities, advancing digital analytics and competencies, accelerating international expansion, and creating a culture of empowerment and accountability.

De Witte has an extensive track record in the global healthcare industry spanning more than two decades. He serves on the board of directors of ResMed, a global leader in digital health technologies and cloud-connected medical devices that transforms care for people with sleep apnea, COPD, and other chronic diseases. He has also been an active community leader, serving as the Chair of the Hangar K innovation hub in Belgium and a board member of Ghent University. De Witte holds a Master of Science in electromechanical engineering with greatest distinction from the KU Leuven in Belgium and a Master of Business Administration from Harvard University.


5. Liam Kelly
Company: Teleflex
Title: Chairman, President, and Chief Executive Officer

Liam Kelly is the Chairman, President, and Chief Executive Officer of Teleflex, a global provider of medical technologies designed to improve the health and quality of people's lives. The company applies purpose-driven innovation, relentlessly pursuing the identification of unmet clinical needs to benefit both patients and healthcare providers. Kelly joined Teleflex in 2009 and has held various positions, including President of EMEA. He was promoted to EVP and President, International three years later. In April 2014, Kelly became EVP and President, Americas, and in 2015, he was named EVP and Chief Operating Officer. From 2016 to 2017, he served as President and Chief Operating Officer.

Prior to his time at Teleflex, Kelly worked at Hill-Rom, serving as the Vice President of International Marketing and Product Development, and also previously held the role of Managing Director for their U.K. & Ireland businesses. Kelly is a director of Enovis Corporation (formerly known as Colfax Corporation) and currently serves on their governance committee. He also serves as a board member for various health-related associations. He holds a Bachelor of Business Studies from the University of Limerick.


6. Daniel Cane
Company: ModMed
Title: Co-Founder and Chief Executive Officer

Daniel Cane is the Co-Founder and Chief Executive Officer of South Florida-based ModMed, a software company with a mission to place doctors and patients at the center of care through an intelligent, specialty-specific cloud platform. Founded in 2010, ModMed is frequently recognized both nationally and regionally for its many achievements under Cane’s leadership. Today, it powers thousands of ambulatory surgical and medical specialty practices and ASCs across the country, improving efficiency for millions of provider and patient interactions. In 2023, ModMed was named Company of the Year by the BIG Innovation Awards.

Before ModMed, Cane co-founded Blackboard Inc. as an undergraduate and raised over $100 million in venture capital. In 2004, he helped take the company public on the NASDAQ (BBBB). He is active in his community and serves on the boards of trustees of Florida Atlantic University, the South Florida Science Center and Aquarium, and the Boca Raton Chamber of Commerce. In 2018, he helped to establish the Cane Institute for Advanced Technologies at Henderson/FAU High School. Cane received his Bachelor of Science in applied economics from Cornell University.


7. Alyson Watson
Company: Modern Health
Title: Founder and Chief Executive Officer

Alyson Watson is the Founder and Chief Executive Officer of Modern Health, a global workplace mental health platform. Modern Health is the first global mental health solution to offer employees access to one-on-one, group, and self-serve digital resources for their emotional, professional, social, financial, and physical well-being needs—all within a single platform. Whether someone wants to proactively manage stress or treat depression, Modern Health guides people to the right care at the right time.

Modern Health empowers companies to help all their employees be the best version of themselves and believes in meeting people wherever they are in their mental health journey. It is backed by investors such as Kleiner Perkins, Founders Fund, John Doerr, Y Combinator, and Battery Ventures and has raised more than $170 million in less than two years with a valuation of $1.17 billion, making Modern Health the fastest entirely female-founded company in the U.S. to reach unicorn status.

Prior to starting Modern Health, Watson held leadership roles including health industry strategy consulting at PwC, healthy behavior change management at Keas (acquired by Welltok), and partner point solution integrations at Collective Health. She graduated from Johns Hopkins University with a degree in global environmental change and sustainability. Watson has been named in the Forbes 30 Under 30 and Fortune 40 Under 40 lists.


8. Jeff Elton
Company: ConcertAI
Title: Chief Executive Officer

Jeff Elton is the Chief Executive Officer of ConcertAI, a prominent healthcare technology company specializing in the application of advanced analytics and artificial intelligence to enhance patient outcomes in the field of oncology. By harnessing the power of extensive data and state-of-the-art algorithms, ConcertAI empowers healthcare providers and researchers to make well-informed decisions related to cancer treatment, clinical trials, and drug development. The company's innovative solutions encompass various areas, including precision medicine, real-world evidence analysis, and patient stratification. ConcertAI is dedicated to driving progress in cancer care through data-driven insights, enabling personalized approaches to cancer treatment.

Prior to his time with ConcertAI, which started in 2018, Elton served as a Global Managing Director of predictive health intelligence at Accenture. He was a Managing Partner at Analysis Group earlier in his career. Elton holds a Ph.D. in business economics and a Master of Business Administration in finance, statistics, and marketing from The University of Chicago Booth School of Business. He obtained his undergraduate degree in economics, biology, and public affairs from the University of Chicago.


9. Dan Rodrigues
Company: Tebra
Title: Co-Founder and Chief Executive Officer

Dan Rodrigues is the Chief Executive Officer and Co-Founder of Tebra, a leading cloud-based healthcare technology platform formed in 2021 with the merger of Kareo and PatientPop. Rodrigues founded Kareo in 2004 with the vision of making medical billing easy for doctors and their staff. Tebra helps 170,000 healthcare providers run more efficient and profitable practices while delivering outstanding patient care. Headquartered in Southern California, Tebra has over 1,000 employees who are passionate about improving healthcare. In 2022, Tebra announced it had secured more than $72 million at an over $1 billion valuation to expand its digital healthcare technology platform. The investment solidified Tebra’s position as the digital backbone for independent practices and accelerated R&D to power a new era of healthcare.

Prior to launching Kareo, Rodrigues started creating technology for the healthcare industry in 2001 as a Co-Founder and Managing Partner of Skematix, a software consulting firm based in Southern California. In the late 1990s, Rodrigues was the Co-Founder and CEO of Scour, a popular search engine for finding music and video files online used by more than 10 million consumers. He began his career as a software developer for RealNetworks and Visio. Rodrigues holds a Bachelor of Science in computer science from the University of California Los Angeles.


10. Suzanne Winter
Company: Accuray Incorporated
Title: President and Chief Executive Officer

Suzanne Winter is the President and Chief Executive Officer of Accuray Incorporated, where she is laser-focused on building a business that grows by making it possible for employees to thrive, customers to excel, and patients with cancer or neurologic conditions to live longer, better lives. Winter has a proven track record in driving life science P&L growth in highly competitive markets through global market and product development as well as commercialization strategies.

Winter has leveraged her expertise to refocus Accuray’s investment in research and development, and high-impact product innovations that improve patient outcomes and differentiate Accuray within a fiercely competitive marketplace. Under her leadership, Accuray introduced the award-winning ClearRT™ Helical Fan-Beam kVCT Imaging, one of the company’s—and the radiation therapy industry’s—most innovative products. Winter has created commercial momentum driven by growing global demand for the company’s advanced radiotherapy solutions that was evident in the FY23 Q3 performance, including record quarterly revenue and unit volume.

Prior to joining Accuray, Winter held senior executive roles spanning general management, commercial operations, and business development across a range of healthcare industry segments, including diagnostic imaging, cardiovascular and neurocritical care, and surgery. Most recently, she served as Group Vice President for Medtronic Diabetes, where she was responsible for $1.4 billion in revenue in the Americas, leading a 2,000-person commercial organization. Before Medtronic, She earned a Master of Business Administration degree from Harvard University Graduate School of Business and a Bachelor of Science degree from Saint Lawrence University in Canton, New York.


11. Jason Gorevic
Company: Teladoc Health
Title: Chief Executive Officer

Jason Gorevic is the Chief Executive Officer and a member of the board of directors at Teladoc Health. Since assuming the role in 2009, he has played a pivotal role in establishing Teladoc Health as the global leader in virtual care. The company has experienced substantial growth in revenue, membership, and telehealth utilization in his time at its head. Gorevic has successfully guided Teladoc Health in shaping the market, driving healthcare transformation, and integrating corporate acquisitions.

Gorevic is widely recognized as a thought leader and innovator in the virtual delivery of healthcare. His career in healthcare began at Oxford Health, and he has held executive leadership positions at WellPoint, Inc. (now Anthem, Inc.) and Empire BlueCross BlueShield. Gorevic earned a Bachelor of Arts in international relations from the University of Pennsylvania.


12. Rajeev Singh
Company: Accolade
Title: Chief Executive Officer

Rajeev Singh is the Chief Executive Officer and Chair of the board of directors at Accolade, which provides care delivery, navigation, and advocacy services to help individuals live their healthiest life. Singh joined Accolade as CEO in November of 2015, and thanks in no small part to his leadership, the company became a publicly traded company in 2020 and integrated four companies in over $1 billion in acquisitions. Accolade launched a new category of healthcare, Personalized Healthcare, in 2022.

Prior to joining Accolade, Singh co-founded Concur, the global leader in travel and expense management. Concur went public in 1998 and grew to more than $800 million in revenue, over 4,000 employees and more than 25,000 customers before being acquired by SAP AG for $8.3 billion in 2014. He serves in a dual role as its President and Chief Operating Officer in addition to sitting on its board of directors. Singh also serves on the board of Amperity, an intelligent customer data platform based in Seattle. He graduated with a Bachelor of Science in engineering from Western Michigan University.

"The opportunity to change even one person's health journey for the better is so powerful. To build something - together with a team of people with the same passion - that could help millions of people and positively impact the trajectories of their lives is worthy of a single-minded obsession. That's why I am here at Accolade." - Rajeev Singh


13. Christian Henry
Company: PacBio
Title: President and Chief Executive Officer

Christian Henry is the President and Chief Executive Officer of PacBio, a premier life sciences technology company that is designing, developing, and manufacturing advanced sequencing solutions to help scientists and clinical researchers resolve genetically complex problems. Their products and technology under development stem from two highly differentiated core technologies focused on accuracy, quality, and completeness, which include its existing HiFi long read sequencing and its emerging SBB® short read sequencing technologies.

Henry has more than two decades of experience with growing companies in the life sciences industry. From 2005 through January 2017, Henry was an executive at Illumina, Inc., where he served in a number of roles including Chief Financial Officer, Chief Commercial Officer, and General Manager of the Life Sciences Business. Prior to Illumina, Henry was Chief Financial Officer for, a publicly traded online ticket provider which was acquired by Major League Baseball Advanced Media, LP.

Henry also served as Vice President of Finance and Corporate Controller for Affymetrix, Inc., and held a similar position at Nektar Therapeutics (formerly Inhale Therapeutic Systems, Inc.). Henry earned a Bachelor of Arts in biochemistry and cell biology from the University of California San Diego and a Master of Business Administration from the University of California Irvine.


14. Stéphane Bancel
Company: Moderna Therapeutics
Title: Chief Executive Officer

Stéphane Bancel has served as Moderna's Chief Executive Officer since October 2011 and as a member of its board of directors since March 2011. Before joining the company, Bancel served for five years as Chief Executive Officer of the French diagnostics company bioMérieux SA. From mid-2000 to 2006, he served in various roles at Eli Lilly and Company, including as Managing Director, Belgium and as Executive Director, Global Manufacturing Strategy and Supply Chain. Prior to Lilly, Bancel served as Asia-Pacific Sales and Marketing Director for bioMérieux.

Bancel currently serves on the board of directors of Indigo and is also a Venture Partner at Flagship Pioneering. He holds a Master of Engineering from École Centrale Paris (ECP), a Master of Science in chemical engineering from the University of Minnesota, and a Master of Business Administration from Harvard Business School.


15. A. Hadi Chaudhry
Company: CareCloud
Title: Chief Executive Officer and President

A. Hadi Chaudhry is the President and Chief Executive Officer of CareCloud, a leading health IT service firm that has been empowering providers for over two decades. He joined CareCloud in 2002 as an IT Manager. Leveraging his background in accounting and IT, Chaudhry was appointed Vice President of Global Operations in 2016. In 2018, he became the company’s President, and today also serves as the CEO alongside fulfilling his presidential duties. Under his leadership, CareCloud hosted its first Virtual Analyst and Investor Day in December 2022, opening new opportunities for product and market diversification for the organization. CareCloud’s EHR systems, Charts, talkEHR, and VertexDR, have all earned ONC certification for interoperability.

Chaudry is a visionary leader who presented an outlook in the full-year 2022 earnings call for 2023 to expand to the non-U.S. market with CareCloud’s tech-enabled innovative solutions, starting with the Middle East. Mirror Review named Hadi Chaudhry in the top 10 dynamic business leaders in the 2023 list, and EY recently shortlisted him in their Entrepreneur of the Year 2023 Finalists for New Jersey Program. Chaudry received a Bachelor of Science in mathematics and statistics from the University of the Punjab.


16. Chris Mansi
Title: Chief Executive Officer

Chris Mansi is the Chief Executive Officer and Co-Founder of While earning his Master of Business Administration at Stanford Graduate School of Business, Mansi joined forces with David Golan, PhD, a machine learning postdoctoral fellow, to found with a goal of using artificial intelligence to make healthcare work faster and smarter, and improve patient access to life-saving treatments.

Under Mansi’s leadership, was a pioneering company in receiving FDA clearance for AI Computer-Aided Triage in 2018 and the first to get CMS New Technology Add-on Payment (NTAP) for AI in 2020. is the leading clinical AI company, having been implemented in over 1,300 hospitals covering over 200 million lives. Mansi is a Cambridge/Queen Square trained neurosurgeon who has practiced medicine at the Queen Square & King's College Hospitals and United Kingdom National Health Service (NHS).


17. David Mou
Company: Cerebral
Title: Chief Executive Officer

David Mou is the Chief Executive Officer of Cerebral, a telemedicine company specializing in mental health. Cerebral offers medication management and therapy services through a monthly membership model. As CEO, Mou is responsible for overseeing the company's clinical strategy, including the development of clinical protocols and new products. He also leads the clinical safety and quality teams to ensure that health network members receive high-quality care.

Prior to joining Cerebral in 2021, Mou co-founded Valera Health, a telepsychiatry company focused on reducing unnecessary hospitalizations for individuals with serious mental illnesses. Mou completed his psychiatry residency at Massachusetts General Hospital and McLean Hospital. He currently serves as the Director of the Innovations Council for the psychiatry department at Massachusetts General Hospital. He graduated from Harvard College with a degree in neurobiology and obtained his medical degree from Harvard Medical School as well as a Master of Business Administration from Harvard Business School.


18. Virgílio Bento
Company: Sword Health
Title: Founder and Chief Executive Officer

Virgílio Bento, Founder and Chief Executive Officer of Sword Health, has devoted his career to bringing positive change to healthcare, using technology to improve patient experiences, outcomes, and value. After his brother suffered an accident and was unable to access the intensive physical therapy needed for recovery, Bento realized there had to be a better way.

While earning a PhD in electrical engineering, he invented the very first Digital Therapist, which used motion tracking technology to deliver physical therapy programs to patients in their homes. Following his PhD, he founded Sword Health to bring this revolutionary therapy to more patients around the world and work toward the company’s mission of freeing 2 billion people from pain.

Since Sword Health's market entry in 2020, the company has become the leader in addressing employers’ number one healthcare cost: back, joint, and muscle pain. From first launching Digital Physical Therapy, to the more recent unveilings of Predict and Bloom, Sword’s individual solutions have catered to specific pain-related issues, empowering members to find effective and convenient solutions. In the company’s latest innovative move, the Sword products have been unified under the Sword Platform, which works to predict, prevent, and treat pain comprehensively.

Bento holds 16 patents and has authored more than 40 research papers in fields as diverse as sensor fusion algorithms, motion tracking systems, and neuroplasticity. His work has been featured in the world’s most distinguished scientific publications and at multiple MedTech conferences.


19. Jonathan Ng
Company: Iterative Scopes
Title: Founder and Chief Executive Officer

Jonathan Ng is the Founder and Chief Executive Officer of Iterative Scopes, a pioneer in the application of artificial intelligence-based precision medicine to gastroenterology with the aim of establishing a new standard of care for the detection, and ultimately, treatment of gastrointestinal diseases. Iterative Scopes is a startup that spun out of MIT, and recently raised $150 million in Series B financing to accelerate development of its core algorithmic innovations. Funding has been raised from top venture firms across the country and the company has been featured in various publications and scored research awards globally.

Ng previously held positions as a Medical Officer at the Ministry of Health Singapore and National University Hospital. Earlier in his career, he worked as a House Officer at Singapore General Hospital. He earned a Master of Business Administration from MIT and a Master of Public Administration in healthcare policy from Harvard Kennedy School. He also holds an undergraduate degree in medicine from the National University of Singapore.


20. Jose Almeida
Company: Baxter International
Title: Chief Executive Officer

José Almeida is the Chairman, President and Chief Executive Officer of Baxter International Inc. Every day, millions of patients and caregivers rely on Baxter's broad portfolio of essential healthcare therapies and technologies, which can be found in patient homes, hospitals, physician offices, and other sites of care worldwide. Almeida assumed his current responsibilities at Baxter in early 2016. He is now leading the company through a period of dynamic evolution and innovation, powered by Baxter's mission to save and sustain lives as well as its vision to transform healthcare.

Before joining Baxter, Almeida was the President and CEO of Covidien from 2011 to 2015 while also acting as Chairman for his last three years with the company. Prior to this, he held a range of senior leadership roles at Covidien’s predecessor organization, Tyco Healthcare, includingPpresident, Medical Devices, and President, International. A career healthcare veteran, Almeida also served in leadership and management roles at multiple companies across the industry, including Wilson Greatbatch Technologies, American Home Products' Acufex Microsurgical division, and Johnson & Johnson's Professional Products division.

He began his career as a Management Consultant at Andersen Consulting (Accenture). Almeida is a member of the Bank of America Board of Directors and the Northwestern University Board of Trustees. A native of Brazil, he received a Bachelor of Science in mechanical engineering from Instituto Mauá de Tecnologia.


21. Saum Sutaria
Company: Tenet Healthcare Corporation
Title: Chief Executive Officer

Saum Sutaria, M.D., became Chief Executive Officer of Tenet in September 2021, and also serves as a Director on the Tenet Board. Prior to his appointment as CEO, Sutaria was the company’s President and Chief Operating Officer with responsibilities spanning the enterprise. He joined Tenet in 2019 after working for nearly two decades at McKinsey & Company, where he was a leader in the healthcare and private equity practices, advising clients on strategic, operational, and financial matters.

Sutaria previously held an associate clinical faculty appointment at the University of California at San Francisco, where he also engaged in postgraduate training with a focus in internal medicine and cardiology. He received his medical degree from the University of California San Diego. He also received a bachelor's degree in molecular and cellular biology and a bachelor's degree in economics, both from the University of California Berkeley.


22. Mike McMullen
Company: Agilent Technologies
Title: Chief Executive Officer and President

Mike McMullen was appointed Agilent’s Chief Executive Officer in 2015, replacing William (Bill) Sullivan. McMullen brings more than 30 years of industry experience and senior management experience at Agilent. He was President of the company's Chemical Analysis Group from 2009 until late 2014. As head of CAG, McMullen transformed the business, consistently delivering market-leading growth and profits, championing strategic acquisitions, and devised Agilent's market strategy in China.

He also built the Agilent CrossLab Group, which includes services, software, and consumables; ACG was made one of Agilent's three major businesses in September 2014. McMullen also has significant international experience, having lived in Japan, where he led Agilent's Japan field sales and support operations, later adding responsibility for China field operations. He is recognized for his inspirational leadership style.

McMullen joined Agilent's predecessor, Hewlett-Packard Co., in 1984 as a Financial Analyst. He holds a bachelor's degree in economics and business administration from the University of Delaware and a Master of Business Administration from the Wharton School of Business. McMullen also serves on the Board of Directors for Coherent, Inc.


23. James Foster
Company: Charles River Laboratories International
Title: Chief Executive Officer

James Foster is Chairman of the Board, President, and Chief Executive Officer of Charles River Laboratories, a leading provider of essential products and services that fully support the drug discovery and early-stage development process. Since beginning his career at Charles River in 1976, Foster has held a variety of positions, including Vice President of Administration and General Counsel, President of Charles River Biotechnical Services, and Executive Vice President.

As CEO, Foster has built Charles River from a niche research models and services business to a full service, early-stage drug research partner catering to more than 100 of the world’s largest biopharmaceutical companies and academic institutions, as well as thousands of emerging and established biotechnology companies. Today, the company offers a unique portfolio of products and services required to take a novel drug therapy from discovery through non-clinical development.

Foster is additionally a Senior Advisor at Cell Signaling Technology. He is Chairman of the Board of Trustees of the Institute of Contemporary Art in Boston, a member of the Presidential Advisory Council for Berklee College of Music, and a frequent guest lecturer at MIT. Foster holds a Bachelor of Arts from Lake Forest College, a Master of Science from MIT, and a Juris Doctor from the Boston University School of Law.


24. John Chiminski
Company: Catalent Pharma Solutions
Title: Chair and Chief Executive Officer

John Chiminski was appointed Catalent’s Executive Chair in July 2022. Prior to that he had served as Chief Executive Officer since 2009 for the New Jersey-based company, which is a global provider of delivery technologies, development, drug manufacturing, biologics, gene therapies, and consumer health products.

Chiminski joined Catalent after more than 20 years of experience at GE Healthcare in engineering, operations, and senior leadership roles. Chiminski was President and Chief Executive Officer of GE Medical Diagnostics, a global business with sales of $1.9 billion. He also served as Vice President and General Manager of GE Healthcare’s Global Magnetic Resonance Business, and was a Vice President and General Manager of Global Healthcare Services. Earlier at GE, he held a series of cross-functional leadership positions in both manufacturing and engineering, including a GE Medical Systems assignment in France. Chiminski has served as a Director of Berkeley Lights.

Chiminski holds a Bachelor of Science from Michigan State University and a Master of Science from Purdue University, both in electrical engineering, as well as a master’s degree in management from the Kellogg School of Management at Northwestern University.


25. Michael Farrell
Company: ResMed
Title: Chief Executive Officer and Director

Michael Farrell has served as the Chief Executive Officer of ResMed since March 2013 and this past January, he was appointed Chair of the company’s board of directors. ResMed is where innovative solutions are being pioneered to treat and prevent hospitalization, empowering individuals to lead healthier and better lives. Farrell initially joined the company in 2000, serving as President of the Americas region from 2011 to 2013 and Senior Vice President of the global sleep apnea business unit from 2007 to 2011, and filling various senior roles in marketing and business development as well along the way.

Before joining ResMed, Farrell worked in management consulting, biotechnology, and chemicals and metals manufacturing at companies including Arthur D. Little, Sanofi Genzyme, Dow Chemical, and BHP. He currently serves on the board of directors of AdvaMed, and also Zimmer Biomet, a global provider of implantable musculoskeletal medical devices. Farrell also volunteers as a trustee for non-profit organizations including the UC San Diego Foundation, Rady Children’s Hospital, and Father Joe’s Villages’ project for the homeless in San Diego, California.

Farrell holds a Bachelor of Engineering with first-class honors from the University of New South Wales, a Master of Science in chemical engineering from MIT, and a Master of Business Administration from the MIT Sloan School of Management.


26. Michelle O'Connor
Title: President and Chief Executive Officer

Michelle O'Connor, as the President and Chief Executive Officer of MEDITECH, spearheads the optimization of the company’s EHR solutions to meet industry standards and enhance the user experience. MEDITECH simplifies and improves clinicians' interactions with patients through their EHR technologies, fostering human connection rather than obstacles. O’Connor has played a vital role in developing MEDITECH's intuitive Expanse user interface and web-based capabilities.

O’Connor first joined MEDITECH as an implementation programmer in 1988, and soon after pursued a management path overseeing process changes and shaping technical support procedures. As Vice President of product development, she was known for her positive approach to problem solving. In this role, O’Connor was instrumental in modernizing the look and feel of the company’s legacy applications, overseeing its physician product development, and working toward an agile development platform. O’Connor is a graduate of Bridgewater State College with a dual degree in math and computer science.


27. Norman Schwartz
Company: Bio-Rad Laboratories
Title: Chief Executive Officer

Norman Schwartz, who has been the head of six different companies, currently occupies the positions of Chairman, President, and Chief Executive Officer at Bio-Rad Laboratories, a global leader in developing and manufacturing a wide range of products for the life sciences research and clinical diagnostic markets. Keeping busy with Bio-Rad’s many subsidiaries, Schwartz is also the current Chairman at DiaMed France SA, Chairman at Bio-Rad Laboratories AB, Co-Managing Director at Bio-Rad AbD Serotec GmbH, Co-Managing Director at Bio-Rad Germany Holding GmbH, and President and Director at RainDance Technologies, Inc. He also sits on the board of eight other companies.

Schwartz previously held the position of Group Manager at Clinical Diagnostics, Inc. as well Life Science Group, Inc. He received an undergraduate degree from San Francisco State University.


28. Stephen MacMillan
Company: Hologic
Title: Chief Executive Officer

Steve MacMillan joined Hologic in late 2013 as its President and Chief Executive Officer, and has led a dramatic turnaround at the company. Hologic is a global, innovative medical technology company which strives to enable healthier lives everywhere, every day.
MacMillan was elected Chairman of the company’s board of directors in June 2015.

Previously, MacMillan served as President and Chief Executive Officer of Stryker, where he had been President since 2003. During his tenure there, MacMillan successfully led the company through a series of key strategic acquisitions, oversaw the launch of a number of products within its orthopedic implant and medical instrumentation businesses, and delivered strong operating performance, with revenue tripling from $2.8 billion to $8.3 billion between 2003 and 2011. Before that, MacMillan was a senior executive with Pharmacia, and also spent over a decade with Johnson & Johnson in a variety of senior roles both in the U.S. and Europe, including as President of the joint venture between Johnson & Johnson and Merck.

MacMillan began his career with Procter & Gamble in 1985. He received a Bachelor of Arts degree in economics from Davidson College, and is a graduate of Harvard Business School’s Advanced Management Program.


29. Mattias Perjos
Company: Getinge
Title: President and Chief Executive Officer

Mattias Perjos is the President and Chief Executive Officer of Getinge, a company that provides hospitals and life sciences institutions with products and solutions to improve clinical results and optimize workflows. Its offerings include solutions for intensive care, cardiovascular procedures, operating rooms, sterile reprocessing, and life sciences.

Perjos joined Getinge from the Coesia Group, a privately owned Italian group of companies, where he held the position as CEO of the IPS Division and was a member of Group management since 2012. In addition to his role as CEO, Perjos was Managing Director of Coesia International, which includes subsidiaries in China, Japan, South Korea, South-East Asia, India, the Americas, Russia, Africa and the Middle East.

Perjos began his career at Sandvik and shortly thereafter joined FlexLink, where he held a number of leading international positions between the years 1997 and 2012, including the role of CEO. During Perjos’ tenure at the helm, FlexLink was acquired by the Coesia group, and the company is now under his responsibility within the Coesia IPS Division. Perjos holds a Master of Science in industrial engineering and management from Luleå University of Technology.


30. Kevin Conroy
Company: Exact Sciences
Title: Chairman and Chief Executive Officer

Kevin Conroy became the Chief Executive Officer of Exact Sciences in 2009 and its Chairman in 2014, transforming the organization into one of the world's premier cancer diagnostics companies and building an expert team of more than 6,500 employees. Conroy led Exact Sciences through the development, clinical trial, regulatory approval, and commercialization of its noninvasive colorectal cancer screening test, Cologuard®. This culminated with Cologuard becoming the first medical device or diagnostic to receive simultaneous FDA approval and national Medicare coverage. Since 2014, millions of Americans have used Cologuard to screen for colorectal cancer, the second leading cause of cancer death in the U.S.

Before joining Exact Sciences, Conroy served as the CEO and President of Third Wave Technologies, held leadership positions at GE Healthcare, and practiced intellectual property law in private practice. He currently serves as a Director of Epizyme, Inc. and Adaptive Biotechnology Corporation.

Conroy serves on the board of the American Clinical Laboratory Association and Personalized Medicine Coalition. He is also active in the Wisconsin community, serving as a Director of the Greater Madison Chamber of Commerce. Conroy holds a Bachelor of Science in electrical engineering from Michigan State University and earned his Juris Doctorate from the University of Michigan Law School.


31. Kevin Sayer
Company: Dexcom
Title: Chairman, President, and Chief Executive Officer

Kevin Sayer is the Chairman of the Board, President, and Chief Executive Officer of Dexcom, a pioneering company in continuous glucose monitoring (CGM). Dexcom's innovative technology has transformed diabetes management since 1999, empowering people to live confidently and pursue their dreams. Sayer has been instrumental in leading Dexcom since assuming the role of CEO in 2015 and later becoming Chairman of the Board. Prior to that, he served as Dexcom's President since 2011 and Chief Operating Officer from 2013 to 2015.

Prior to leading Dexcom, Sayer held various management positions, serving as Chief Financial Officer of Biosensors International Group, Ltd., Executive Vice President and Chief Financial Officer of Specialty Laboratories, Inc., Chief Financial Officer of MiniMed, Inc., and Vice President and General Manager of Medtronic MiniMed after the acquisition of MiniMed by Medtronic. Sayer received a bachelor’s degree as well as a master's degree in accounting and information systems from Brigham Young University.


32. Roy Schoenberg
Company: Amwell
Title: President and Chief Executive Officer

Roy Schoenberg is the President and Chief Executive Officer of Amwell. Since co-founding the company with his brother Ido, Schoenberg has helped Amwell grow to become one of the largest telehealth eco-systems in the world, digitally connecting healthcare’s key stakeholders – payers, providers, and millions of patients in an efficient, modern healthcare experience.

Prior to Amwell, Schoenberg was the founder of CareKey and served as Chief Information Security Officer at TriZetto following its acquisition of CareKey. In 2013, he was appointed to the Federation of State Medical Boards’ Taskforce that issued the landmark guidelines for the Appropriate Use of Telemedicine in the Practice of Medicine. In the fall of 2020, Schoenberg was also appointed to eHealth Initiative's Board of Directors.

An inventor at heart, Schoenberg holds over 50 issued U.S. patents in the area of healthcare technology, speaks frequently in industry and policy forums, and serves on the healthcare advisory board of MIT Sloan. He holds an MD from the Hebrew University and a Master of Public Health from Harvard.


33. Jean-Jacques Bienaimé
Company: BioMarin Pharmaceutical
Title: Chief Executive Officer

Jean Jacques Bienaimé is the Chief Executive Officer of BioMarin Pharmaceutical Inc., the fastest growing and largest private employer in Marin County. Under his leadership, BioMarin has grown in number of employees, market capital, and overall stature, and is now a fully integrated biopharmaceutical company with more than 1,300 employees. Bienaimé brings over 30 years of experience in the biotechnology and pharmaceutical industries.

Previously, Bienaimé served as Chairman, CEO, and President of Genencor, a biotechnology company focused on industrial bioproducts and targeted cancer biotherapeutics. Prior to that, Bienaimé filled the same three aforementioned roles at Sangstat Medical Corporation, an immunology-focused biotechnology company that he guided to profitability prior to its acquisition by Genzyme Corporation.

Bienaimé currently serves on the boards of biotechnology companies Intermune, Inc., and Vital Therapies, Inc., as well as the Biotech Industry Organization (BIO). He received a Master of Business Administration from the Wharton School at the University of Pennsylvania and a degree in economics from the École Supérieure de Commerce de Paris.


34. Joe Kiani
Company: Masimo
Title: Chief Executive Officer

Joe Kiani is an engineer and entrepreneur known for his 30-year career dedicated to solving complex problems and improving patient safety through consumer and medical technology. He co-invented Masimo SET® technology, revolutionizing pulse oximetry and transforming patient care in hospitals and homes. In 1989, he founded Masimo, which has grown into a successful publicly traded company with thousands of patents under its belt. Masimo's technologies monitor over 200 million people annually. Kiani serves as the company’s Chairman and Chief Executive Officer, driving innovation in professional healthcare, telemonitoring, consumer wearables, and audio solutions.

Kiani founded the Patient Safety Movement Foundation in 2012, aiming to eliminate preventable medical errors worldwide and achieve zero preventable deaths by 2030. Collaborating with experts, he created 18 Actionable Patient Safety Solutions which have been widely adopted by hospitals and clinicians. He also established the Masimo Foundation for Ethics, Innovation, and Competition in Healthcare, supporting positive change and innovation in patient care. Kiani chairs the Masimo Foundation's Board of Directors.

Beyond Masimo, Kiani is CEO of Cercacor, focusing on health and wellness innovation. He also co-founded A Starting Point, a civic engagement platform, with Chris Evans and Mark Kassen. Additionally, Kiani co-founded Like Minded Media Ventures, connecting art, technology, and impactful storytelling about social causes and science. He earned a Bachelor of Science as well as a Master of Science in electrical engineering from San Diego State University.


35. John Oyler
Company: BeiGene
Title: Chief Executive Officer

John Oyler is the Founder and Chief Executive Officer of BeiGene, a global biotechnology company based in China. BeiGene focuses on discovering and developing accessible and affordable oncology treatments for cancer patients worldwide. With a commercial presence in over 60 markets, BeiGene offers products for various forms of cancer and has a pipeline that can potentially address 80% of cancers by incidence.

Oyler has held many notable positions, including CEO of BioDuro and Galenea as well as President of Telephia. He also worked as a Consultant for McKinsey & Company. Oyler graduated from MIT with a Bachelor of Science in mechanical engineering and later earned his Master of Business Administration from the Stanford University Graduate School of Business.


36. Curt Hartman
Company: CONMED
Title: President and Chief Executive Officer

Curt Hartman is the President and Chief Executive Officer of CONMED, a global medical technology company specializing in surgical and patient monitoring products and services. CONMED's innovative offerings enable physicians to deliver high-quality care and achieve enhanced clinical outcomes. The company's products are widely recognized as technological game changers in various specialties, including orthopedics, laparoscopy, robotics, gastroenterology, pulmonology, cardiology, and critical care.

Before joining CONMED, Hartman served as an interim CEO and CFO at Stryker. He is currently also the Chairman of the board of directors at medical device company Olympus Veran Technologies. Hartman holds an undergraduate degree in aerospace engineering from the University of Michigan.


37. Daniel Perez
Company: Hinge Health
Title: Chief Executive Officer and Co-Founder

Daniel Perez is the Chief Executive Officer and Co-Founder of Hinge Health, a company that he established in 2014 with the aim of pioneering the world's most patient-centered digital clinic, starting with musculoskeletal health. Motivated by his passion for helping others and alleviating pain, Perez company provides advanced wearable technology and comprehensive clinical care to individuals suffering from musculoskeletal issues. Hinge Health has achieved remarkable success, having raised over $1 billion in funding to date.

Prior to co-founding Hinge Health, Perez founded the Oxbridge Biotech Roundtable while pursuing his PhD at Oxford University. He also co-founded and served as the CEO of Marblar. Daniel Perez holds a Bachelor of Science in biology from Westminster College.


38. Shashank ND
Company: Practo
Title: Founder and Chief Executive Officer

As the Founder and Chief Executive Officer of India’s leading integrated healthcare company, Shashank ND is heading efforts towards building products and services aimed at improving access to quality healthcare for people worldwide. He also mentors and guides organizations on digital healthcare strategies to build and boost practices that deliver high-quality, patient-focused care.

In recognizing the profound need to transform the healthcare industry and make it more connected, integrated, and efficient, Practo has strengthened its delivery across a wide portfolio of services including online consultation, in-person appointment booking, medicine delivery, and at-home diagnostics, and successfully forayed into secondary care offerings with the support of a strong network of doctor partners and other healthcare professionals. Shashank ND earned a bachelor’s degree from National Institute of Technology Karnataka.


39. Stephen Krupa
Company: HealthEdge
Title: Chief Executive Officer

Stephen Krupa is the Chief Executive Officer of HealthEdge, a company driving digital transformation through transaction automation as well as real-time business and clinical engagement among payers, providers, and patients. The next-generation SaaS company provides an integrated ecosystem of advanced solutions for core administration (HealthRules® Payer), payment integrity (Source), care management (GuidingCare®) and member experience (Wellframe), empowering health plans to leverage new business models, reduce costs, and improve outcomes across healthcare delivery.

Krupa began his career as a Mechanical Engineer and Programmer at Johnson Controls, controlling large mechanical systems using software and digital interfaces. Later, he worked in healthcare mergers and acquisitions, playing a key role in securing over $12 billion of strategic acquisitions and recapitalizations, including the acquisition of U.S. Healthcare by Aetna. He also spent 18 years as a Healthcare VC Partner at the Psilos Group, investing in transformative healthcare technology and services companies such as ActiveHealth Management, Extend Health, and HealthEdge.

Under Krupa’s leadership, HealthEdge has been recognized as a Best Place to Work by the Boston Globe, Boston's Best and Brightest, and Best and Brightest Companies to Work for in the Nation. Krupa also hosts the podcast Breaking Health, where he interviews disruptive CEOs and leaders in healthcare. He holds a Master of Business Administration from the Wharton School of the University of Pennsylvania and a Bachelor of Science in mechanical engineering from the University of South Florida.


40. Chris Johnson
Company: Landmark Health
Title: Chief Executive Officer

Chris Johnson is the Chief Executive Officer of Landmark Health. Operating under the umbrella of Optum and the UnitedHealth Group, Landmark is a mobile provider group specializing in delivering medical care directly to the homes of adults living with chronic illnesses. By offering healthcare services in the comfort of patients' homes, they assist individuals in achieving their personal health and life objectives while minimizing the need for hospitalization.

Johnson joined Landmark in 2017 as Vice President and General Manager responsible for launching the New England market. He has also served as Landmark’s Head of Corporate Development, where was responsible for the company’s growth strategy, strategic partnerships, mergers and acquisitions, and public policy. In this position, Johnson played an integral role in spearheading Landmark’s merger with Optum, and leading the company’s integration into Optum’s Home and Community platform.

Prior to Landmark, he was a Principal at Innosight, a healthcare focused growth strategy consultancy and additionally co-founded Predilytics, a healthcare analytics business. Johnson holds a Bachelor of Arts in economics from Harvard College and received a Master of Business Administration from Harvard Business School.


41. Tim Walbert
Company: Horizon Therapeutics
Title: Chairman, President and Chief Executive Officer

Tim Walbert is the President, Chief Executive Officer, and Chairman of Horizon, a leading global biotechnology company focused on developing and distributing pharmaceuticals for rare, autoimmune, and severe inflammatory diseases.

Prior to joining Horizon, Walbert held various executive positions in the biopharmaceutical industry. He was the President, CEO, and Director of IDM Pharma Inc., which was later acquired by Takeda. Before that, he served as the Executive Vice President of Commercial Operations at NeoPharm Inc. Additionally, Walbert worked at Abbott (now AbbVie) as its Divisional Vice President and General Manager, leading the global development and launch of the biologic HUMIRA. He also held positions at G.D. Searle & Company, Merck, and Wyeth, where he focused on sales and marketing.

Walbert currently serves on the boards of Aurinia Pharmaceuticals Inc. and the Executive's Club of Chicago. He is a member of the National Organization for Rare Disorders (NORD) Advisory Board and the Wall Street Journal CEO Council. Moreover, Walbert serves on the Board of Trustees of Muhlenberg College. He previously served on the boards of Raptor Pharmaceutical Corp., XOMA Corporation, and Sucampo Pharmaceuticals Inc. He received his Bachelor of Arts in business from Muhlenberg College.


42. Tushar Vashisht
Company: HealthifyMe
Title: Co-Founder and Chief Executive Officer

Tushar Vashisht is the Chief Executive Officer and Co-Founder of HealthifyMe, the company behind a leading consumer health app. He has a diverse background, having worked as an investment banker and being an early employee at Aadhaar. Vashisht’s career began on Wall Street as an intern for BlackRock. He later joined Deutsche Bank as a corporate finance analyst in San Francisco before moving to Singapore. In 2009, he joined the Aadhaar project in Bangalore, which was headed by Nandan Nilekani. Many of Vashisht’s colleagues from this project would later become board members and early investors in HealthifyMe.

In 2012, he co-founded HealthifyMe with Mathew Cherian and Sachin Shenoy. Their vision was to provide online tools to help the people of India lead healthier lives. HealthifyMe started as India's first comprehensive calorie tracker, and eventually expanded to include digital nutritionists and trainers as part of its subscription service. The organization introduced AI-powered "Smart Plans" in 2019, which were personalized plans based on customer habits and medical conditions. The same year, HealthifyMe became the top-rated Indian startup on the Google Play Store. Vashisht is a graduate of the University of Pennsylvania.


43. Eren Bali
Company: Carbon Health
Title: Chief Executive Officer

Eren Bali is a technology luminary focused on education and healthcare accessibility, and as the Co-Founder and Chief Executive Officer of Carbon Health, he is dedicated to making essential healthcare services more readily available. Carbon Health utilizes its innovative technology platform to offer advanced primary care to patients, delivering care through various channels such as in-person clinics, virtual care, and remote patient monitoring. With over 100 clinics nationwide and a strong virtual care presence, Carbon Health is revolutionizing healthcare in the post-pandemic era.

Before Carbon Health, Bali co-founded Udemy, an online learning platform that has empowered over 50 million students worldwide. With more than 64,000 instructors offering 185,000 courses in over 75 languages, Udemy has played a pivotal role in making education accessible globally. Bali pursued higher education at Middle East Technical University, graduating with a double major in computer engineering and mathematics.


44. Joseph Papa
Company: Bausch & Lomb, Bausch Health
Title: Chairman and Chief Executive Officer

Joseph Papa is an American businessman currently serving as the Chairman and Chief Executive Officer of Bausch & Lomb, a global company focused on eye health that provides a wide range of products that protect and enhance vision for individuals throughout their lives. Its portfolio includes over 400 products, such as contact lenses, lens care products, eye care products, ophthalmic pharmaceuticals, over-the-counter products, and ophthalmic surgical devices and instruments. Since the IPO of Bausch & Lomb's eye health business in mid-2022, Papa has held his current positions. Previously, he served as the Chairman and CEO of Bausch Health Companies Inc.

Before joining Bausch Health, Papa was the Chairman and CEO of Perrigo, a prominent American manufacturer of private label over-the-counter pharmaceuticals. Prior to that, he held the roles of Chairman and CEO of the pharmaceutical and technologies services division of Cardinal Health, an Ohio-based healthcare services company. Papa also served as the President and Chief Operating Officer of Watson Pharmaceuticals, Inc. He has also worked at other notable companies such as Novartis and Pharmacia/Searle, where he played a crucial role in launching medications such as Celebrex, Diovan, and Lotrel.

Papa earned a bachelor's degree in pharmacy from the University of Connecticut and completed his Master of Business Administration with a focus on marketing and finance at Northwestern University's Kellogg Graduate School of Management.


45. Jim Hollingshead
Company: Insulet Corporation
Title: President and Chief Executive Officer

Jim Hollingshead is the President and Chief Executive Officer of Insulet Corporation, an innovative medical device company founded in 2000 with the mission of improving the lives of people with diabetes. Specifically, through its revolutionary Omnipod Insulin Management System, the company seeks to expand the use of insulin pump therapy.

Before joining Insulet, Hollingshead served as President of the Sleep and Respiratory Care (SRC) business at ResMed Inc., a global medical technology company specializing in sleep-related breathing disorders. He held various positions during his time there, including President, Americas, Chief Strategy Officer, and President, Ventures & Initiatives. Prior to his time at ResMed, Hollingshead had an extensive career in strategy consulting, focusing on biotech, high-tech, and telecommunications industries. He was a senior partner at Deloitte Consulting, specializing in Strategy and Life Sciences practices, and also served as a Managing Partner at Monitor Group, a U.S. strategy consulting firm.

Hollingshead received a Bachelor of Arts in history and international relations with Highest Distinction from Stanford University. He also holds a master's degree as well as a Ph.D. in political science from the University of California Berkeley.


46. Ali Parsa
Company: Babylon
Title: Founder and Chief Executive Officer

Ali Parsa is the Founder and Chief Executive Officer of Babylon, a revolutionary artificial intelligence and digital health company. Babylon’s mission is to put an accessible and affordable health service in the hands of every person worldwide. By combining cutting-edge AI technology and the best-available medical expertise, Babylon gives people 24/7 access to affordable, holistic health services. This includes video doctor consultations, health assessment, triage, and general health tools.

Prior to founding Babylon, Parsa established Circle, which grew to become Europe's largest clinician partnership, generating £200 million in revenue, employing 3,000 individuals, and successfully going public. Parsa received the Entrepreneurial Achievement award from the Independent Healthcare Awards for his role in establishing Circle. He was also honored with the Royal Award for Young Entrepreneur of the Year for his first business venture, V&G. Parsa served as a U.K. Cabinet Office Ambassador for Mutuals and chaired the Tech Forum at the Confederation of British Industry (CBI). He holds a Ph.D. in engineering physics.


47. Quentin Blackford
Company: iRhythm Technologies
Title: President and Chief Executive Officer

Quentin Blackford serves as the President and Chief Executive Officer of iRhythm Technologies, a digital healthcare company redefining the way cardiac arrhythmias are clinically diagnosed by combining wearable biosensing technology with cloud-based data analytics and machine- learning capabilities.

Blackford held various roles prior to joining iRhythm Technologies, most recently as Chief Operating Officer at Dexcom Inc., a company that develops, manufactures, produces, and distributes continuous glucose monitoring systems for diabetes management. Blackford was also the Chief Financial Officer at Nuvasive Inc., a medical device company for minimally invasive spine surgery, and was the Director of Finance and Controller of the Dental Division at Zimmer Holdings, Inc., a medical device company.

Blackford has served as an independent member of the Board of Directors of Alphatec Holdings, Inc. and Paragon 28, Inc. He received dual Bachelor of Science degrees in accounting and business administration from Grace College.


48. Steve Griggs
Company: AdaptHealth
Title: Chief Executive Officer

Steve Griggs became Co-Chief Executive Officer of AdaptHealth after the acquisition of AeroCare in 2021. AdaptHealth is a network of medical equipment companies that provide personalized products and services to enable patients to live comfortably at home. The company is a full-service home medical equipment and respiratory solutions leader with operations in 46 states, offering a breadth of clinically-focused products and services to help patients with daily activities of life including sleep and respiratory therapy, mobility products, wound care, non-invasive ventilation, and nutrition.

Griggs founded AeroCare in 2000 and served as its CEO. Prior to that, he held various roles at Rotech Medical Corporation, including Chief Financial Officer, Chief Operating Officer, and President. He began his career as a CPA, and later worked as a controller for a tourist and entertainment conglomerate in Orlando, Florida, where he successfully led financial turnaround efforts. Griggs holds an undergraduate degree in Business Management from East Tennessee State University and an undergraduate degree in accounting from the University of Central Florida.


49. Peggy Johnson
Company: Magic Leap
Title: Chief Executive Officer

Peggy Johnson is the Chief Executive Officer of Magic Leap, an AR technology company founded in 2010 that specializes in creating immersive experiences through its flagship product, the Magic Leap One, an AR headset that blends virtual objects with the real world using sensors, cameras, and a high-resolution display. The technology is based on spatial computing, making virtual objects appear in the physical environment. Magic Leap's applications span gaming, entertainment, education, and enterprise sectors.

Johnson has 34 years of experience and began her career in 1989. Prior to her role at Magic Leap, she served as an Executive Vice President of business development at Microsoft. She also worked with Qualcomm as an EVP of global market development. Johnson holds an undergraduate degree in electrical and electronics engineering from San Diego State University.


50. Amir Aghdaei
Company: Envista
Title: President and Chief Executive Officer

Amir Aghdaei is the founding President and Chief Executive Officer of Envista, a global family of more than 30 trusted dental brands. Envista's mission is to partner with dental professionals to improve patient care through innovative products, solutions, and technology.

Aghdaei’s journey with Danaher began in 2008, when he joined as the Multi-Brand General Manager and Vice President of Fluke. He quickly progressed within the company, assuming various leadership positions. He was appointed President of Tektronix in 2009, became a Group Executive in 2011, and took on the role of President for the Danaher Communications Platform and Danaher Russia in 2014. In 2015, he became the President of Dental Technologies, and in 2018, he assumed the role of President of Danaher's Dental Platform. Before joining Danaher, Aghdaei was the Vice President of Credence, and also served as the General Manager and Vice President of the Measurement Systems Divisions at Agilent Technologies.

Aghdaei holds a Bachelor of Science in industrial engineering from the Technology and Science University of Iran. He also earned master's degrees in applied mathematics and computer science from Georgia State University. Additionally, he holds a Master of Business Administration from the University of Delaware.